NASDAQ:XERS
Xeris Biopharma Holdings, Inc.
- Stock
Last Close
7.71
06/11 22:33
Market Cap
319.49M
Beta: -
Volume Today
1.82M
Avg: 1.25M
PE Ratio
−4.97
PFCF: −4.75
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|
average inventory | 1.09M - | 5.26M 383.87% | 13.24M 151.41% | 21.43M 61.89% | 31.79M 48.35% | ||||
average payables | 1.65M - | 1.42M 13.64% | 3.23M 127.62% | 4.36M 34.80% | 6.02M 38.08% | 6.76M 12.37% | 8.09M 19.52% | ||
average receivables | 650K - | 2.03M 212.92% | 4.25M 109.14% | 6.26M 47.09% | 12.17M 94.43% | 24.14M 98.45% | 35.01M 45.03% | ||
book value per share | -14.72 - | -26.65 81.09% | 6.26 123.48% | 0.55 91.17% | 0.79 43.20% | 1.21 52.21% | 0.33 72.35% | -0.00 100.01% | |
capex per share | -0.02 - | -0.32 1,900% | -0.13 61.15% | -0.04 66.18% | -0.01 79.15% | -0.01 55.30% | -0.00 71.86% | -0.00 99.57% | |
capex to depreciation | -0.30 - | -3.95 1,210.73% | -4.72 19.32% | -1.03 78.24% | -0.26 74.97% | -0.58 124.69% | -0.04 92.84% | -0.18 343.71% | |
capex to operating cash flow | 0.00 - | 0.03 1,204.55% | 0.03 5.47% | 0.01 60.46% | 0.00 55.89% | 0.01 142.68% | 0.01 55.16% | 0.05 844.98% | |
capex to revenue | -0.03 - | -0.45 1,281.75% | -0.61 36.17% | -0.41 33.61% | -0.02 95.40% | -0.02 16.97% | -0.00 78.28% | -0.01 190.47% | |
cash per share | 14.87 - | 19.38 30.30% | 9.35 51.75% | 2.89 69.05% | 3.14 8.43% | 1.30 58.69% | 0.90 30.62% | 0.00 99.94% | |
days of inventory on hand | 495.47 - | 326.85 34.03% | 496.55 51.92% | 398.88 19.67% | |||||
days payables outstanding | 60.00K - | 180.31K 200.53% | 7.53K 95.83% | 1.28K 83.05% | 121.97 90.44% | 244.58 100.53% | 74.28 69.63% | ||
days sales outstanding | 34.29 - | 281.26 720.16% | 424.82 51.04% | 756.15 77.99% | 124.50 83.53% | 128.48 3.20% | 102.07 20.56% | 87.28 14.49% | |
debt to assets | 0.03 - | 0.06 111.25% | 0.33 487.99% | 0.53 60.11% | 0.55 2.21% | 0.29 47.08% | 0.57 98.68% | 0.71 23.58% | |
debt to equity | -0.03 - | -0.04 56.54% | 0.53 1,302.83% | 4.04 659.41% | 2.58 36.18% | 0.92 64.12% | 4.38 373.96% | -33.79 871.02% | |
dividend yield | 0.33 - | 0.46 38.28% | |||||||
earnings yield | -0.30 - | -0.61 101.03% | -0.29 51.53% | -0.68 132.53% | -0.43 36.32% | -0.53 22.01% | -0.52 0.99% | -0.00 99.96% | |
enterprise value | 11.60M - | 1.82M 84.28% | 190.96M 10,370.07% | 222.86M 16.71% | 259.23M 16.32% | 252.35M 2.65% | 256.48M 1.64% | 323.70B 126,109.14% | |
enterprise value over ebitda | -0.88 - | -0.07 92.17% | -3.31 4,675.02% | -1.86 43.65% | -3.22 72.59% | -2.20 31.55% | -3.61 63.84% | -7.36K 203,787.55% | |
ev to operating cash flow | -0.72 - | -0.07 89.74% | -3.39 4,488.27% | -2.14 37.05% | -3.22 50.66% | -2.64 17.92% | -2.49 5.63% | -6.88K 276,058.14% | |
ev to sales | 10.79 - | 1.17 89.14% | 77.47 6,509.10% | 81.87 5.69% | 12.86 84.29% | 5.09 60.44% | 2.33 54.28% | 1.97K 84,787.84% | |
free cash flow per share | -7.43 - | -11.69 57.32% | -4.80 58.96% | -4.04 15.81% | -1.90 53.01% | -1.22 35.58% | -0.76 37.64% | -0.00 99.95% | |
free cash flow yield | -0.37 - | -0.58 57.32% | -0.28 51.19% | -0.57 103.00% | -0.39 32.66% | -0.42 8.17% | -0.57 37.39% | -0.00 99.97% | |
graham net net | -15.27 - | -27.60 80.80% | 5.82 121.10% | -0.52 109.00% | 0.42 179.33% | -1.07 357.30% | -1.05 2.22% | -0.00 99.86% | |
graham number | 44.90 - | 85.68 90.80% | 26.50 69.06% | 7.74 70.82% | 6.17 20.23% | 6.49 5.16% | 2.29 64.75% | 0.00 99.97% | |
income quality | 1.22 - | 0.93 23.74% | 0.94 0.86% | 0.83 11.30% | 0.88 6.38% | 0.78 11.93% | 1.09 39.63% | 0.76 30.51% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0.51 Infinity% | 0.36 28.67% | 0.41 13.67% | |
interest coverage | -6.62K - | -13.31K 101.26% | -23.32 99.82% | -17.09 26.73% | -7.84 54.13% | -16.04 104.64% | -5.35 66.66% | 1.65 130.93% | |
interest debt per share | 0.42 - | 1.18 183.08% | 3.54 200.17% | 2.51 29.18% | 2.29 8.64% | 1.21 47.38% | 1.57 30.54% | 0.00 99.91% | |
inventory turnover | 0.74 - | 1.12 51.59% | 0.74 34.18% | 0.92 24.49% | |||||
invested capital | -0.03 - | -0.04 56.54% | 0.53 1,302.83% | 4.04 659.41% | 2.58 36.18% | 0.92 64.12% | 4.38 373.96% | -33.79 871.02% | |
market cap | 43.87M - | 43.87M 0% | 204.78M 366.81% | 184.08M 10.11% | 209.80M 13.98% | 231.55M 10.37% | 180.39M 22.10% | 323.54B 179,257.35% | |
net current asset value | -32.29M - | -58.77M 82.01% | 73.28M 224.67% | -7.07M 109.65% | 26.82M 479.49% | -66.53M 348.06% | -112.52M 69.11% | -173.12M 53.86% | |
net debt to ebitda | 2.46 - | 1.60 35.10% | 0.24 85.00% | -0.32 235.45% | -0.61 89.07% | -0.18 70.41% | -1.07 489.81% | -3.68 243.39% | |
net income per share | -6.09 - | -12.24 101.03% | -4.99 59.25% | -4.81 3.57% | -2.14 55.56% | -1.55 27.34% | -0.70 55.06% | -0.00 99.94% | |
operating cash flow per share | -7.41 - | -11.37 53.31% | -4.67 58.90% | -4.00 14.46% | -1.89 52.73% | -1.21 36.01% | -0.76 37.25% | -0.00 99.95% | |
payables turnover | 0.01 - | 0.00 66.73% | 0.05 2,295.84% | 0.29 489.90% | 2.99 946.02% | 1.49 50.13% | 4.91 229.27% | ||
receivables turnover | 10.64 - | 1.30 87.81% | 0.86 33.79% | 0.48 43.82% | 2.93 507.33% | 2.84 3.10% | 3.58 25.88% | 4.18 16.94% | |
research and ddevelopement to revenue | 9.52 - | 12.96 36.08% | 16.49 27.26% | 22.20 34.63% | 1.04 95.33% | 0.51 51.12% | 0.19 62.52% | 0.14 28.33% | |
return on tangible assets | -0.39 - | -0.59 49.81% | -0.50 15.18% | -1.15 130.20% | -0.57 50.30% | -0.82 42.82% | -0.43 47.37% | -0.33 23.87% | |
revenue per share | 0.50 - | 0.72 44.74% | 0.20 71.47% | 0.10 49.05% | 0.47 353.38% | 0.63 32.76% | 0.81 29.54% | 0.00 99.85% | |
roe | 0.41 - | 0.46 11.01% | -0.80 273.52% | -8.70 991.82% | -2.70 68.97% | -1.29 52.26% | -2.09 62.55% | 9.18 538.19% | |
roic | 0.43 - | 0.48 13.02% | -0.53 209.85% | -1.68 216.74% | -0.69 58.79% | -0.63 9.07% | -0.32 49.46% | -0.17 45.78% | |
sales general and administrative to revenue | 3.78 - | 5.15 36.39% | 8.57 66.28% | ||||||
shareholders equity per share | -14.72 - | -26.65 81.09% | 6.26 123.48% | 0.55 91.17% | 0.79 43.20% | 1.21 52.21% | 0.33 72.35% | -0.00 100.01% | |
stock based compensation to revenue | 0.50 - | 0.32 36.16% | 0.70 118.59% | 2.38 239.80% | 0.41 82.77% | 0.23 44.09% | 0.11 51.94% | 0.07 40.73% | |
tangible asset value | -31.93M - | -57.83M 81.09% | 75.41M 230.39% | 14.44M 80.86% | 33.76M 133.87% | -59.08M 274.99% | -79.41M 34.42% | -139.41M 75.55% | |
tangible book value per share | -14.72 - | -26.65 81.09% | 6.26 123.48% | 0.55 91.17% | 0.79 43.20% | -0.75 194.42% | -0.59 21.68% | -0.00 99.83% | |
working capital | 30.65M - | 39.19M 27.89% | 107.73M 174.86% | 60.15M 44.17% | 124.00M 106.18% | 63.56M 48.75% | 113.20M 78.11% | 61.07M 46.05% |
All numbers in USD (except ratios and percentages)